Eisai Partners With Sirutasu and Wellmira on Dietary Behavior Change
Eisai Co., Ltd. announced on November 10, 2026, that it will advance separate collaborations with SIRUTASU Inc. and Wellmira Inc. to support personalized dietary behavior changes aimed at reducing the risk of cognitive decline.
- Eisai partnered with SIRUTASU and Wellmira to integrate nutritional guidance into consumer health applications.
- The initiatives utilize the “Guidance on Nutrition for Reducing the Risk of Cognitive Decline,” supervised by the National Center for Geriatrics and Gerontology (NCGG).
- SIRUTASU’s collaboration was selected for Japan’s METI Orange Innovation Project, incorporating insights from people living with dementia.
The new initiatives use insights from the "Guidance on Nutrition for Reducing the Risk of Cognitive Decline," developed by Eisai under the supervision of the National Center for Geriatrics and Gerontology (NCGG), as reported by Eisai. Eisai compiled the guidance after reviewing domestic and international literature from the perspective of World Health Organization (WHO) nutritional interventions, alongside a companion guide for home-delivered meals and meal kits, according to corporate announcements.
Under these separate agreements, the guidance will be integrated into two digital health platforms. SIRUTASU will incorporate the insights into its “SIRU+” healthcare app, which visualizes nutritional balance and dietary trends using daily purchasing data, as detailed by Eisai. Simultaneously, Wellmira will update its AI-powered “CALOmama PLUS” health management app, which utilizes personal health records including life-log data on diet, exercise, and sleep to deliver tailored health advice.
Eisai’s collaboration with SIRUTASU earned selection for the “Orange Innovation Project,” part of the Japanese Ministry of Economy, Trade and Industry’s FY2026 Project for Advancing the Healthcare Industry Infrastructure, as reported by Eisai. This project positions individuals living with dementia as service development partners to refine information communication, service usability, and food recommendations.
Both platforms also plan to offer optional integration with Eisai’s “NouKNOW” brain health self-assessment tool—which is not classified as a medical device—and “Theotol,” a portal website operated by Eisai Group company Theoria technologies, Co., Ltd. These integrations aim to connect users to personalized nutrition improvements and sustained behavioral changes while promoting accurate understanding of mild cognitive impairment and dementia.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.